When the first continuous positive airway pressure machine (CPAP) was developed, ResMed founder, Peter Farrell saw the potential to help treat patients with sleep apnea.
ResMed commercialised CPAP, making it quieter, smaller, more comfortable and more accessible to millions worldwide. They have since expanded their product range to provide solutions for the whole journey – from diagnosis to treatment.
While sleep apnea remains a focus for ResMed, they are also a global top 5 producer of hospital-to-home ventilators and a top 2 producer of non-invasive ventilation devices, also known as bi-level devices. With the Australian Government’s support, ResMed produced 7000 of these life-saving devices for Australia’s medical stockpile in the first half of 2020.
ResMed’s innovative technology has the potential to improve quality of life, reduce the impact of chronic disease and save healthcare costs.